These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 22624471

  • 1. [In vitro investigation of the antiviral activity of Ingavirin against human metapneumovirus].
    Isaeva EI, Nebol'sin VE, Kozulina IS, Morozova OV.
    Vopr Virusol; 2012; 57(1):34-8. PubMed ID: 22624471
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Experimental study of Ingavirin antiviral activity against human adenovirus].
    Zarubaev VV, Slita AV, Sirotkin AK, Nebol'sin VE, Kiselev OI.
    Antibiot Khimioter; 2010; 55(9-10):19-24. PubMed ID: 21400749
    [Abstract] [Full Text] [Related]

  • 6. [In vitro activity of Ingavirin against influenza virus A (H3N2)].
    Loginova SIa, Borisevich SV, Semenova IV, Maksimov VA, Bondarev VP, Nebol'sin VE.
    Antibiot Khimioter; 2009; 54(9-10):23-6. PubMed ID: 20415259
    [Abstract] [Full Text] [Related]

  • 7. Antiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters.
    Jochmans D, van Nieuwkoop S, Smits SL, Neyts J, Fouchier RA, van den Hoogen BG.
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4620-9. PubMed ID: 27185803
    [Abstract] [Full Text] [Related]

  • 8. [In vitro efficacy of ingavirin against the Mexican pandemic subtype H1N1 of influenza A virus, strains A/California/04/2009 and A/California/07/2009].
    Loginova SIa, Borisevich SV, Lykov MV, Vedenina EV, Borisevich GV, Bondarev VP, Nebol'sin VE, Chuchalin AG.
    Antibiot Khimioter; 2009 Aug; 54(3-4):15-7. PubMed ID: 19711843
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [In vitro efficacy of Ingavirin against the pandemic influenza virus A(H1N1/09)v].
    Shishkina LN, Nebol'sin VE, Kabanov AS, Skarnovich MO, Erdyneeva UB, Mazurkova NA, Serova OA, Stavskiĭ EA, Drozdov IG.
    Antibiot Khimioter; 2010 Aug; 55(3-4):12-6. PubMed ID: 20695202
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Therapeutic efficacy of Ingavirin, a new domestic formulation against influenza A virus (H3N2)].
    Loginova SIa, Borisevich SV, Maksimov VA, Bondarev VP, Nebol'sin VE.
    Antibiot Khimioter; 2008 Aug; 53(7-8):27-30. PubMed ID: 19227120
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Investigation of prophylactic activity of Ingavirin, a new Russian drug, against grippe A virus (H3N2)].
    Loginova SIa, Borisevich SV, Maksimov VA, Bondarev VP, Nebol'sin VE.
    Antibiot Khimioter; 2008 Aug; 53(11-12):19-21. PubMed ID: 19441652
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The effect of ingavirin on the ultrastructural properties of morphogenesis of parainfluenza in vitro and in vivo].
    Zarubaeva VV, Garshinina AV, Kalinina NA, Beliaeskaia SV, Sirotkin AK, Nebol'sin VE, Kuselev OI, Reĭkhart DV.
    Vopr Virusol; 2012 Aug; 57(5):32-8. PubMed ID: 23248857
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Human metapneumovirus infection activates the TSLP pathway that drives excessive pulmonary inflammation and viral replication in mice.
    Lay MK, Céspedes PF, Palavecino CE, León MA, Díaz RA, Salazar FJ, Méndez GP, Bueno SM, Kalergis AM.
    Eur J Immunol; 2015 Jun; 45(6):1680-95. PubMed ID: 25763996
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.